Keyphrases
Moderate to Severe
100%
Alzheimer's Disease
100%
Donepezil
100%
Double-blind Randomized Trial
100%
Economic Evaluation
100%
Placebo
33%
Caregivers
33%
Placebo Groups
22%
Health Care Costs
22%
Efficacy Outcomes
11%
Patient Management
11%
Placebo Treatment
11%
Donepezil Treatment
11%
Total Annual Cost
11%
Functional Benefit
11%
Instrumental Activities of Daily Living Scale
11%
Progressive Deterioration
11%
Multinational Clinical Trials
11%
Societal Perspective
11%
Improved Strategies
11%
Cost-effective Treatment
11%
Cost Difference
11%
Cost Offset
11%
Unit Cost
11%
Clinician Judgement
11%
Average Cost Rate
11%
Total Saving
11%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Donepezil
100%
Placebo
60%
Deterioration
10%
Clinical Trial
10%
5 Nitro 2 (3 Phenylpropylamino)benzoic Acid
10%
Neuroscience
Alzheimer's Disease
100%
Donepezil
100%
Placebo
60%